Medicare’s new GLP‑1 bridge program launches soon, easing access without shortages, and pharamcists are at the focal point of these transitions.
Cristy Gallagher, MPAff
Advertisement
Articles by Cristy Gallagher, MPAff
CMS pilots BALANCE and GLP-1 Bridge models to widen Medicare/Medicaid obesity drug coverage, spotlighting pharmacists’ role in access and safe therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Committee Votes Unanimously to Recommend mRNA Flu Vaccine
2
Metformin Cuts Long COVID Risk by Half in New ACTIV-6 Trial Results
3
How Will Emerging AI Impact the Pharmacy Benefit Manager Space?
4
McKesson Partners with Pharmacies to Grow, Navigate Challenges
5